+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Membrane-binding properties of phospholipase C-beta1 and phospholipaseC-beta2: role of the C-terminus and effects of polyphosphoinositides, G-proteins and Ca2+



Membrane-binding properties of phospholipase C-beta1 and phospholipaseC-beta2: role of the C-terminus and effects of polyphosphoinositides, G-proteins and Ca2+



Biochemical Journal 327: 431-437



We have studied the binding of two G-protein-regulated phospholipase C (PLC) enzymes, PLCs-beta1 and -beta2, to membrane surfaces using sucrose-loaded bilayer phospholipid vesicles of varying compositions. Neither enzyme binds appreciably to pure phosphatidylcholine vesicles at lipid concentrations up to 10(-3) M. PLC-beta1 and PLC-beta2 bind vesicles composed of phosphatidylcholine, phosphatidylserine and phosphatidylethanolamine (molar ratio 1:1:1) with an approximate Kd of 10(-5) M. Inclusion of 2% PtdIns(4,5)P2 in these vesicles had no effect on the affinity of this interaction. As reported by others, removal of the C-terminus of PLC-beta1 and PLC-beta2 produces catalytically active fragments. The affinity of these truncated proteins for phospholipid vesicles is dramatically reduced suggesting that this region of the proteins contains residues important for membrane binding. Inclusion of G-protein alpha- and betagamma-subunit activators in the phospholipid vesicles does not increase the binding of PLC-beta1 or PLC-beta2, and the magnitude of G-protein-mediated PLC activation observed at low phospholipid concentrations (10(-6) M) is comparable to that observed at concentrations at which the enzymes are predominantly membrane-bound (10(-3) M). PLC-beta1 and -beta2 contain C2 domains but Ca2+ does not enhance binding to the vesicles. Our results indicate that binding of these enzymes to membranes involves the C-temini of the proteins and suggest that activation of these enzymes by G-proteins results from a regulated interaction between the membrane-bound proteins rather than G-protein-dependent recruitment of soluble enzymes to a substrate-containing phospholipid surface.

(PDF emailed within 1 workday: $29.90)

Accession: 046661856

Download citation: RISBibTeXText

PMID: 9359412


Related references

Membrane-binding properties of phospholipase C-β1 and phospholipaseC-β2: role of the C-terminus and effects of polyphosphoinositides, G-proteins and Ca2+. Biochemical Journal 327(2): 431-437, 1997

Role of the N-terminus in the interaction of pancreatic phospholipase A2 with aggregated substrates. Properties and crystal structure of transaminated phospholipase A2. Biochemistry 23(12): 2759-2766, 1984

Binding properties of beta-blockers at recombinant beta1-, beta2-, and beta3-adrenoceptors. Journal of Cardiovascular Pharmacology 36(4): 466-471, 2000

Binding relationships of membrane tethering components. The giantin N terminus and the GM130 N terminus compete for binding to the p115 C terminus. Journal of Biological Chemistry 275(14): 10196-10201, 2000

Binding properties of beta-adrenoceptor antagonists used in heart failure at recombinant beta1, beta2 and beta3-adrenoceptors. European Heart Journal 20(ABSTR SUPPL ): 28, 1999

Laminin binding to beta1-integrins selectively alters beta1- and beta2-adrenoceptor signalling in cat atrial myocytes. Journal of Physiology 527 Pt 1: 3-9, 2000

Confinement of beta1- and beta2-adrenergic receptors in the plasma membrane of cardiomyocyte-like H9c2 cells is mediated by selective interactions with PDZ domain and A-kinase anchoring proteins but not caveolae. 2013

Effects of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles. Journal of Pharmacological Sciences 107(4): 393-400, 2008

Characterization of a CMTX-beta1 mutation for dominant negative effects on wild type beta1 and beta2 connexins. Molecular Biology of the Cell 11(Supplement): 331a, 2000

Appearance of Langerhans cells in the epidermis of TGF-beta1-/- SCID mice Paracrine and autocrine effects of TGF-beta1 and TGF-beta2. FASEB Journal 15(4): A674, March 7, 2001

Dual role of the beta2-adrenergic receptor C terminus for the binding of beta-arrestin and receptor internalization. Journal of Biological Chemistry 283(46): 31840-8, 2008

Interaction via a key tryptophan in the I-II linker of N-type calcium channels is required for beta1 but not for palmitoylated beta2, implicating an additional binding site in the regulation of channel voltage-dependent properties. Journal of Neuroscience 25(30): 6984-6996, 2005

Role of Galphaq and phospholipase C-beta2 in human platelets activation by thrombin receptors PAR1 and PAR4: studies in human platelets deficient in Galphaq and phospholipase C-beta2. British Journal of Haematology 121(3): 491-496, 2003

Arabidopsis Type-III Phosphatidylinositol 4-Kinases beta1 and beta2 are Upstream of the Phospholipase C Pathway Triggered by Cold Exposure. 2012

The effect of beta2-adrenoceptor agonists on phospholipase C (beta1) signalling in human airway smooth muscle cells. European Journal of Pharmacology 531(1-3): 9-12, 2006